Back to Agenda
Strategic Priorities of the International Coalition of Medicines Regulatory Authorities in an Increasingly Globalized Industry
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development, Bill and Melinda Gates Foundation, United States
The International Coalition of Medicines Regulatory Authorities (ICMRA) will explore its strategic priorities in the context of a globalized world. To overcome these challenges ICMRA can champion greater harmonisation and convergence. The session will be delivered by members of ICMRA and conclude with a panel discussion of questions raised by the audience.
Learning Objective : Describe strategic priorities of ICMRA in the context of the globalized world.
Speaker(s)
Overview of ICMRA and Strategic Priorities: Including Vigilance, Track, and Trace
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology, Tor Vergata University of Rome, Italy
The 'Innovation' Priority Project
Chief Executive, Health Products Regulatory Authority , Ireland
Current Topics of Interest to ICMRA Members Including Biosimilars and AMR
Enterprise Professor, Health Research Impact, University of Melbourne, Australia
Panelist
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
IFPMA View
Senior Vice President, EISA EUROPE LTD, United Kingdom
Have an account?